The MBT STAR®-Carba IVD Kit (STAR – Selective Testing of Antibiotic Resistance) in conjunction with the MBT STAR®-BL IVD software allows rapid microorganism identification and detection of carbapenemase activity in one workflow.
The MBT STAR®-Carba IVD Kit is the first mass spectrometric resistance detection assay, expanding the application of the IVD-CE MALDI Biotyper® MALDI-TOF mass spectrometry system in clinical microbiology beyond the identification of microorganisms.
To counteract the rise of multidrug-resistant bacteria, Bruker is dedicated to developing new solutions to keep pace. The rapid identification and determination of resistance is a crucial basis for clinicians and physicians to provide their patients with the antibiotic that promises rapid, gentle and appropriate treatment, as fast as possible.